Protumorinflammation.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title IL-1ß and Pro-Tumor Inflammation (PTI)
Description Learn how Pro-Tumor Inflammation (PTI) is one of the drivers of tumor survival, growth, and progression. IL-1β plays a key role in PTI.
Keywords
Server Information
WebSite protumorinflammation favicon www.protumorinflammation.com
Host IP 217.114.85.70
Location Sweden
Related Websites
Site Rank
More to Explore
psengine.co.uk
retrorush.nl
rinchupeco.com
rmbsoft.com
rnqxtzd.top
roers-parts.ru
rogdestvenskij.ru
rosliny-owadozerne.pl
rubymall.co.kr
saintaugustinespriory.sharepoint.com
bagofjerks.com
baltix.fr
Protumorinflammation.com Valuation
US$12,132
Last updated: Mar 27, 2021

Protumorinflammation.com has global traffic rank of 1,409,496. Protumorinflammation.com has an estimated worth of US$ 12,132, based on its estimated Ads revenue. Protumorinflammation.com receives approximately 2,216 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.70. According to SiteAdvisor, protumorinflammation.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$12,132
Daily Ads Revenue US$6
Monthly Ads Revenue US$199
Yearly Ads Revenue US$2,426
Daily Unique Visitors 2,216
Note: All traffic and earnings values are estimates.
Traffic Ranks
Global Rank 1,409,496
Delta (90 Days) 0
Most Popular In Country N/A
Country Rank N/A
DNS Records
Host Type TTL Data
protumorinflammation.com A 599 IP: 217.114.85.70
protumorinflammation.com NS 1799 Target: a7-64.akam.net.
protumorinflammation.com NS 1799 Target: a2-66.akam.net.
protumorinflammation.com NS 1799 Target: dns3.novartis.com.
protumorinflammation.com NS 1799 Target: a9-65.akam.net.
protumorinflammation.com NS 1799 Target: a28-67.akam.net.
protumorinflammation.com NS 1799 Target: a1-254.akam.net.
protumorinflammation.com NS 1799 Target: dns1.novartis.com.
protumorinflammation.com NS 1799 Target: a24-65.akam.net.
protumorinflammation.com NS 1799 Target: dns2.novartis.com.
protumorinflammation.com NS 1799 Target: dns4.novartis.com.
protumorinflammation.com SOA 21599 MNAME: dns1.novartis.com.
RNAME: hostmaster.novartis.com.
Serial: 2020120701
Refresh: 86400
Retry: 3600
Expire: 2592000
Minimum TTL: 172800
HTTP Headers
HTTP/1.0 301 Moved Permanently
Location: http://www.protumorinflammation.com/
Server: BigIP
Connection: Keep-Alive
Content-Length: 0

HTTP/1.1 301 Moved Permanently
Date: Sat, 27 Mar 2021 19:34:06 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 160
Connection: close
Set-Cookie: __cfduid=d65cb66a0839f6831b783e1ea36d17fca1616873646; expires=Mon, 26-Apr-21 19:34:06 GMT; path=/; domain=.protumorinflammation.com; HttpOnly; SameSite=Lax
Location: https://www.protumorinflammation.com/
X-Powered-By: ASP.NET
Set-Cookie: ARRAffinity=69e773f2a9c1f64efde6a16e27e80702b636e76f3187c575565bb2b8f8a626ab;Path=/;HttpOnly;Domain=www.protumorinflammation.com
CF-Cache-Status: DYNAMIC
cf-request-id: 0916c702ff000015c715be0000000001
Server: cloudflare
CF-RAY: 636b0de4cb5615c7-EWR

HTTP/2 200 
date: Sat, 27 Mar 2021 19:34:07 GMT
content-type: text/html; charset=utf-8
set-cookie: __cfduid=d28414ba06a64086594baf1e4e867f4d81616873647; expires=Mon, 26-Apr-21 19:34:07 GMT; path=/; domain=.protumorinflammation.com; HttpOnly; SameSite=Lax
cache-control: private
vary: Accept-Encoding
set-cookie: ASP.NET_SessionId=slr0egh4ypog3yfplp4u4mst; path=/; HttpOnly; SameSite=Lax
set-cookie: ASP.NET_SessionId=slr0egh4ypog3yfplp4u4mst; path=/; HttpOnly; SameSite=Lax
set-cookie: __RequestVerificationToken=h2OzTlW_GpvIacez5y3f5SmxlC4b8fwH0GpaWefsAzQAYJFvO3_N3aqyE3Npwdt21aCTffprPB7YxEHruTeLNF_8Yw1NSTFk_gIHVAUfH-Q1; path=/; HttpOnly
x-aspnetmvc-version: 5.2
content-security-policy: default-src 'self' 'unsafe-inline' 'unsafe-eval' fonts.googleapis.com fonts.gstatic.com www.googletagmanager.com www.google-analytics.com unpkg.com assets.adobedtm.com stats.g.doubleclick.net novartispharmaag.d3.sc.omtrdc.net cdn.cookielaw.org geolocation.onetrust.com analytics.google.com api.fouanalytics.com *.vo.msecnd.net dc.services.visualstudio.com *.b2c.com www.google.com *.idio.episerver.net
x-frame-options: SAMEORIGIN
x-aspnet-version: 4.0.30319
request-context: appId=cid-v1:fbded6d8-2f5c-4cb0-adf7-2ae9d814644f
access-control-expose-headers: Request-Context
x-powered-by: ASP.NET
set-cookie: ARRAffinity=e6e459c1f0103ac9cab1433180ea58d4eee8c1f7df808c362c27fdb3c6e510ac;Path=/;HttpOnly;Secure;Domain=www.protumorinflammation.com
set-cookie: ARRAffinitySameSite=e6e459c1f0103ac9cab1433180ea58d4eee8c1f7df808c362c27fdb3c6e510ac;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.protumorinflammation.com
cf-cache-status: DYNAMIC
cf-request-id: 0916c703a10000ccd60e8b9000000001
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 636b0de5cffeccd6-EWR

Protumorinflammation.com Whois Information
   Domain Name: PROTUMORINFLAMMATION.COM
   Registry Domain ID: 2501848474_DOMAIN_COM-VRSN
   Registrar WHOIS Server: whois.markmonitor.com
   Registrar URL: http://www.markmonitor.com
   Updated Date: 2020-12-08T23:04:24Z
   Creation Date: 2020-03-10T09:52:07Z
   Registry Expiry Date: 2022-03-10T09:52:07Z
   Registrar: MarkMonitor Inc.
   Registrar IANA ID: 292
   Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
   Registrar Abuse Contact Phone: +1.2083895740
   Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
   Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
   Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
   Name Server: A1-254.AKAM.NET
   Name Server: A2-66.AKAM.NET
   Name Server: A24-65.AKAM.NET
   Name Server: A28-67.AKAM.NET
   Name Server: A7-64.AKAM.NET
   Name Server: A9-65.AKAM.NET
   Name Server: DNS1.NOVARTIS.COM
   Name Server: DNS2.NOVARTIS.COM
   Name Server: DNS3.NOVARTIS.COM
   Name Server: DNS4.NOVARTIS.COM
   DNSSEC: unsigned
   URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/

Domain Name: protumorinflammation.com
Registry Domain ID: 2501848474_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2021-03-27T00:10:01-0700
Creation Date: 2020-03-10T02:52:07-0700
Registrar Registration Expiration Date: 2022-03-10T01:52:07-0800
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895770
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registry Registrant ID: 
Registrant Name: Domain Admin
Registrant Organization: Novartis AG
Registrant Street: P.O. Box CH-4002, 
Registrant City: Basel
Registrant State/Province: CH
Registrant Postal Code: 4002
Registrant Country: CH
Registrant Phone: +1.2083895740
Registrant Phone Ext: 
Registrant Fax: +1.2083895799
Registrant Fax Ext: 
Registrant Email: novartis.domains@markmonitor.com
Admin Organization: MarkMonitor, Inc.
Admin State/Province: ID
Admin Country: US
Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/protumorinflammation.com
Tech Organization: MarkMonitor, Inc.
Tech State/Province: ID
Tech Country: US
Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/protumorinflammation.com
Name Server: dns3.novartis.com
Name Server: dns4.novartis.com
Name Server: a7-64.akam.net
Name Server: a9-65.akam.net
Name Server: dns1.novartis.com
Name Server: a24-65.akam.net
Name Server: dns2.novartis.com
Name Server: a1-254.akam.net
Name Server: a28-67.akam.net
Name Server: a2-66.akam.net
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/

MarkMonitor Domain Management(TM)
Protecting companies and consumers in a digital world.

Visit MarkMonitor at https://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220